Nahdi Medical Company
TADAWUL:4164.SR
132.8 (SAR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SAR.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,472.7 | 2,257.497 | 2,214.25 | 2,162.9 | 2,231.485 | 2,105.036 | 2,138.242 | 2,158.983 | 2,239.469 | 2,079.494 | 1,973.23 | 2,041.739 | 2,070.136 | 1,981.111 | 1,986.141 | 2,135.55 | 2,423.572 | 2,260.258 |
| Cost of Revenue
| 1,534 | 1,402.847 | 1,349.19 | 1,288.728 | 1,335.396 | 1,218.113 | 1,306.435 | 1,247.926 | 1,313.166 | 1,227.767 | 1,166.023 | 1,183.943 | 1,210.168 | 1,201.4 | 1,276.175 | 1,357.322 | 1,476.596 | 1,407.173 |
| Gross Profit
| 938.7 | 854.65 | 865.06 | 874.173 | 896.09 | 886.923 | 831.807 | 911.056 | 926.303 | 851.727 | 807.206 | 857.796 | 859.968 | 779.711 | 709.967 | 778.228 | 946.977 | 853.085 |
| Gross Profit Ratio
| 0.38 | 0.379 | 0.391 | 0.404 | 0.402 | 0.421 | 0.389 | 0.422 | 0.414 | 0.41 | 0.409 | 0.42 | 0.415 | 0.394 | 0.357 | 0.364 | 0.391 | 0.377 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 85.877 | 80.584 | -186.207 | 92.165 | 81.27 | 80.369 | -173.671 | 94.136 | 81.086 | 67.273 | -160.108 | 63.54 | 88.391 | 60.412 | 49.18 | 81.87 | 105.146 | 89.795 |
| Selling & Marketing Expenses
| 585.22 | 557.049 | -1,261.508 | 559.569 | 547.937 | 548.631 | -1,286.21 | 553.331 | 552.186 | 533.294 | -1,201.04 | 525.301 | 516.439 | 494.948 | 477.138 | 583.907 | 540.502 | 448.797 |
| SG&A
| 671.097 | 631.449 | -1,447.715 | 651.734 | 629.207 | 629 | -1,459.881 | 647.467 | 633.273 | 600.568 | -1,361.148 | 588.841 | 604.83 | 555.36 | 508.318 | 665.777 | 645.647 | 538.592 |
| Other Expenses
| -665.3 | 8.438 | 3.772 | 0.216 | 0.001 | 0.013 | -0.386 | 3.192 | 0.606 | 1.047 | 6.7 | 2.991 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 665.3 | 623.011 | 702.79 | 644.393 | 613.167 | 623.677 | 694.553 | 632.556 | 620.491 | 587.354 | 692.776 | 583.521 | 600.331 | 553.547 | 518.747 | 662.964 | 639.236 | 533.077 |
| Operating Income
| 273.4 | 231.64 | 865.06 | 229.779 | 282.922 | 263.246 | 153.892 | 278.5 | 305.812 | 264.373 | 159.829 | 274.275 | 259.637 | 226.164 | 210.89 | 115.265 | 307.741 | 320.008 |
| Operating Income Ratio
| 0.111 | 0.103 | 0.391 | 0.106 | 0.127 | 0.125 | 0.072 | 0.129 | 0.137 | 0.127 | 0.081 | 0.134 | 0.125 | 0.114 | 0.106 | 0.054 | 0.127 | 0.142 |
| Total Other Income Expenses Net
| -273.4 | 10.699 | -865.06 | -7.179 | -6.221 | -0.904 | -15.332 | -13.631 | -18.697 | -16.991 | -9.089 | -15.061 | -19.249 | -19.238 | -32.504 | -10.918 | -12.84 | -14.151 |
| Income Before Tax
| 260.607 | 242.339 | 182.602 | 222.6 | 276.702 | 262.342 | 138.56 | 264.869 | 287.114 | 247.382 | 150.74 | 259.214 | 240.388 | 206.926 | 178.386 | 104.347 | 294.901 | 305.856 |
| Income Before Tax Ratio
| 0.105 | 0.107 | 0.082 | 0.103 | 0.124 | 0.125 | 0.065 | 0.123 | 0.128 | 0.119 | 0.076 | 0.127 | 0.116 | 0.104 | 0.09 | 0.049 | 0.122 | 0.135 |
| Income Tax Expense
| 12.871 | 9.389 | 12.084 | 9.795 | 11.75 | 18 | 10.575 | 11.057 | 18.607 | 9.875 | 7.508 | 11.763 | 13.56 | 11.908 | 11.58 | 11.25 | 24.258 | 11.25 |
| Net Income
| 247.736 | 232.95 | 170.518 | 212.805 | 264.952 | 244.343 | 127.985 | 253.812 | 268.507 | 237.507 | 143.232 | 247.451 | 226.828 | 195.018 | 166.806 | 93.097 | 270.643 | 294.606 |
| Net Income Ratio
| 0.1 | 0.103 | 0.077 | 0.098 | 0.119 | 0.116 | 0.06 | 0.118 | 0.12 | 0.114 | 0.073 | 0.121 | 0.11 | 0.098 | 0.084 | 0.044 | 0.112 | 0.13 |
| EPS
| 1.91 | 1.79 | 1.31 | 1.64 | 2.04 | 1.88 | 0.98 | 1.95 | 2.07 | 1.83 | 1.1 | 1.9 | 1.74 | 1.5 | 0.76 | 0.93 | 2.71 | 2.95 |
| EPS Diluted
| 1.91 | 1.79 | 1.31 | 1.64 | 2.04 | 1.88 | 0.98 | 1.95 | 2.07 | 1.83 | 1.1 | 1.9 | 1.74 | 1.5 | 0.76 | 0.93 | 2.71 | 2.95 |
| EBITDA
| 462.96 | 393.616 | 315.23 | 396.101 | 445.194 | 435.943 | 298.528 | 438.89 | 451.683 | 410.067 | 275.328 | 414.931 | 404.905 | 363.496 | 237.657 | 155.649 | 346.039 | 358.306 |
| EBITDA Ratio
| 0.187 | 0.174 | 0.142 | 0.183 | 0.2 | 0.207 | 0.14 | 0.203 | 0.202 | 0.197 | 0.14 | 0.203 | 0.196 | 0.183 | 0.12 | 0.073 | 0.143 | 0.159 |